| Literature DB >> 26157475 |
Amir A Krausz1, Michael M Krausz2, Edoardo Picetti3.
Abstract
Severe maxillofacial and neck trauma exposes patients to life threatening complications such as airway compromise and hemorrhagic shock. These conditions require rapid actions (diagnosis and management) and a strong interplay between surgeons and anesthesiologists. Effective airway management often makes the difference between life and death in severe maxillofacial and neck trauma and takes initial precedence over all other clinical considerations. Damage control strategies focus on physiological and biochemical stabilization prior to the comprehensive anatomical and functional repair of all injuries. Damage control surgery (DCS) can be defined as the rapid initial control of hemorrhage and contamination, temporary wound closure, resuscitation to normal physiology in the intensive care unit (ICU) and subsequent reexploration and definitive repair following restoration of normal physiology. Damage control resuscitation (DCR) consists mainly of hypotensive (permissive hypotension) and hemostatic (minimal use of crystalloid fluids and utilization of blood and blood products) resuscitation. Both strategies should be administered simultaneously in all of these patients.Entities:
Keywords: Damage control resuscitation; Damage control surgery; Massive transfusion; Maxillofacial trauma; Neck trauma
Year: 2015 PMID: 26157475 PMCID: PMC4495937 DOI: 10.1186/s13017-015-0022-9
Source DB: PubMed Journal: World J Emerg Surg ISSN: 1749-7922 Impact factor: 5.469
Fig. 1Role of damage control strategies (DCS and DCR) in severely injured patients. DCS = damage control surgery. DCR = damage control resuscitation
Scores for massive transfusion
| TASH score | 1. SBP: < 100 mmHg = 4 pts, < 120 mmHg = 1 pt |
| (0–28 pts, Increasing TASH-scores were associated with an increasing probability for MT requirement) | 2. Hb: < 7 g/dl = 8 pts, < 9 g/dl = 6 pts, < 10 g/dl = 4 pts, < 11 g/dl = 3 pts, < 12 g/dl = 2 pts |
| 3. intra-abdominal fluid : 3 pts | |
| 4. complex long bone and/or pelvic fractures: AIS 3 or 4 = 3 pts, AIS 5 = 6 pts | |
| 5. HR: > 120 bpm = 2 pts | |
| 6. BE: < -10 mmol/l = 4 pts, < -6 mmol/l = 3 pts, < -2 mmol/l = 1 pt | |
| 7. gender: male = 1 pt | |
| ABC score | 1. penetrating mechanism: no = 0 pt, yes = 1 pt |
| (0–4 pts, a score of 2 or greater was used to predict the need for MT) | 2. SBP < 90 mmHg: no = 0 pt, yes = 1 pt |
| 3. HR > 120 bpm: no = 0 pt, yes = 1 pt | |
| 4. positive FAST: no = 0 pt, yes = 1 pt |
TASH trauma associated severe hemorrhage, SBP systolic blood pressure, pts points, pt point, Hb hemoglobin, AIS abbreviated injury score, HR heart rate, bpm beats per minute, BE base excess, FAST focused assessment with sonography for trauma, MT massive transfusion
Hemostatic/Hemodynamic resuscitation following major trauma
| Tranexamic Acid | within 3 h of injury loading dose 1 g over 10 min, followed by 1 g over 8 h |
| Ionized Calcium Levels | maintain in normal ranges during MT |
| Plasma : RBC | at least 1:2 (preferably 1:1) maintain Hb levels: 7–9 g/dl maintain coagulation parameters (repeated monitoring of PT, aPTT, fibrinogen levels, platelets count, viscoelastic testing) in normal ranges during MT |
| Fibrinogen | 3–4 g administer in case of thromboelastometric signs of a functional fibrinogen deficit or a plasma fibrinogen level of less than 1.5 to 2 g/l |
| Platelet Count | 50 × 109/l if ongoing bleeding and/or TBI: 100 × 109/l initial dose 4–8 single platelet units or 1 aphaeresis pack |
| Blood Pressure | SBP: 80 to 90 mmHg until hemorrhage control (no TBI) if severe TBI (GCS ≤ 8) MAP ≥ 80 mmHg |
| consider rFVIIa if major bleeding and traumatic coagulopathy persist despite maximal attempts to stop bleeding | |
| in case of pre-trauma therapeutic anticoagulation or antiplatelets drugs consider specific treatment (ex. desmopressin, PCC, etc) |
MT massive transfusion, Hb hemoglobin, PT prothrombin time, aPTT activated partial thromboplastin time, TBI traumatic brain injury, SBP systolic blood pressure, MAP mean arterial pressure, GCS Glasgow Coma Scale, rFVIIa recombinant activated coagulation factor VII, PCC prothrombin complex concentrate